Toni K. Choueiri - The Cancer Letter

CCC19 bridging the knowledge gap for patients with COVID-19 and cancer
First results to be heard at 2020 ASCO Annual Meeting

As the healthcare system faces the onslaught of the novel coronavirus SARS-CoV-2, clinicians caring for individuals with cancer face the challenge of a wide gap in knowledge needed to guide decision-making.

May 22, 2020

Vol.46 No.21

By Rana R. McKay, Toni K. Choueiri, Brian I. Rini and Jeremy L. Warner

Clinical Free Trials & Tribulations

Cabozantinib in first-line treatment of metastatic renal cell carcinoma

Systemic therapies for metastatic renal cell carcinoma (mRCC) have expanded dramatically over the past 3 years.

January 05, 2018

Vol.44 No.01

By Tian Zhang, Michael J. Morris, Darren R. Feldman, Toni K. Choueiri and Daniel J. George

Toni K. Choueiri, MD

CCC19 bridging the knowledge gap for patients with COVID-19 and cancer
First results to be heard at 2020 ASCO Annual Meeting

Cabozantinib in first-line treatment of metastatic renal cell carcinoma

Renew today!

Subscriber content

Login

Toni K. Choueiri, MD

CCC19 bridging the knowledge gap for patients with COVID-19 and cancerFirst results to be heard at 2020 ASCO Annual Meeting

Cabozantinib in first-line treatment of metastatic renal cell carcinoma

Login

CCC19 bridging the knowledge gap for patients with COVID-19 and cancer
First results to be heard at 2020 ASCO Annual Meeting